FDA removes black-box warnings from three more menopause patches without adviser review
Researcher faults transparency as officials cite updated evidence and patch shortages
The US Food and Drug Administration said Friday that three more patches for treating menopause will no longer carry black-box warnings about cardiovascular disease, breast cancer and dementia, a decision it made without convening an advisory committee and with few details on the scientific basis offered at a press briefing.